• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Imaging Genomics of Glioma Revisited: Analytic Methods to Understand Spatial and Temporal Heterogeneity.胶质瘤的影像基因组学再探讨:理解空间和时间异质性的分析方法。
AJNR Am J Neuroradiol. 2024 May 9;45(5):537-548. doi: 10.3174/ajnr.A8148.
2
Radiogenomics of Gliomas.脑胶质瘤的放射组学
Radiol Clin North Am. 2021 May;59(3):441-455. doi: 10.1016/j.rcl.2021.02.002.
3
Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas.超越有创活检:利用 VASARI MRI 特征预测胶质瘤的分级和分子参数。
Cancer Imaging. 2024 Jan 2;24(1):3. doi: 10.1186/s40644-023-00638-8.
4
Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma.基于不同磁共振成像序列的影像组学分析在胶质瘤分级和分子基因组分型中的比较。
J Comput Assist Tomogr. 2021;45(1):110-120. doi: 10.1097/RCT.0000000000001114.
5
Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.基于定量 MRI 特征的 II/III 级脑胶质瘤患者的分子分类。
J Neurooncol. 2018 Sep;139(3):633-642. doi: 10.1007/s11060-018-2908-3. Epub 2018 Jun 2.
6
Imaging Genomics in Gliomas.胶质瘤中的影像基因组学
Cancer J. 2015 May-Jun;21(3):225-34. doi: 10.1097/PPO.0000000000000120.
7
Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.使用 MRI 和基于 MRI 的放射组学无创测定脑胶质瘤 IDH 状态:对诊断和预后的影响。
Curr Oncol. 2022 Sep 23;29(10):6893-6907. doi: 10.3390/curroncol29100542.
8
Survival and immune microenvironment prediction of glioma based on MRI imaging genomics method: a retrospective observational study.基于MRI成像基因组学方法的胶质瘤生存及免疫微环境预测:一项回顾性观察研究
Neurosurg Rev. 2025 Jan 3;48(1):18. doi: 10.1007/s10143-024-03164-8.
9
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.弥散加权和灌注加权 MRI 放射组学模型可预测弥漫性低级别胶质瘤中的异柠檬酸脱氢酶 (IDH) 突变和肿瘤侵袭性。
Eur Radiol. 2020 Apr;30(4):2142-2151. doi: 10.1007/s00330-019-06548-3. Epub 2019 Dec 11.
10
Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis.MRI 放射组学研究在预测胶质母细胞瘤 MGMT 启动子甲基化中的质量评估:系统评价和荟萃分析。
Eur Radiol. 2024 Sep;34(9):5802-5815. doi: 10.1007/s00330-024-10594-x. Epub 2024 Feb 3.

引用本文的文献

1
Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part I: high-grade group.小儿型弥漫性胶质瘤中具有启发性的放射基因组特征:分子、临床和影像相关性洞察。第一部分:高级别组。
Radiol Med. 2025 Aug 25. doi: 10.1007/s11547-025-02078-9.
2
Imaging-Based Molecular Characterization of Adult-Type Diffuse Glioma Using Diffusion and Perfusion MRI in Pre- and Post-Treatment Stage Considering Spatial and Temporal Heterogeneity.考虑空间和时间异质性,在治疗前和治疗后阶段使用扩散加权磁共振成像(DWI)和灌注加权磁共振成像(PWI)对成人型弥漫性胶质瘤进行基于影像的分子特征分析
J Magn Reson Imaging. 2025 Aug;62(2):468-479. doi: 10.1002/jmri.29781. Epub 2025 Apr 8.

本文引用的文献

1
Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI.基于 MRI 的深度学习放射组学模型在异柠檬酸脱氢酶突变型星形细胞瘤中 CDKN2A/B 纯合缺失状态的术前鉴别
J Magn Reson Imaging. 2024 May;59(5):1655-1664. doi: 10.1002/jmri.28945. Epub 2023 Aug 9.
2
A novel MRI-based deep learning networks combined with attention mechanism for predicting CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma.一种新型基于 MRI 的深度学习网络结合注意力机制,用于预测 IDH 突变型星形细胞瘤中 CDKN2A/B 纯合缺失状态。
Eur Radiol. 2024 Jan;34(1):391-399. doi: 10.1007/s00330-023-09944-y. Epub 2023 Aug 8.
3
Radiomics for characterization of the glioma immune microenvironment.用于表征神经胶质瘤免疫微环境的放射组学
NPJ Precis Oncol. 2023 Jun 19;7(1):59. doi: 10.1038/s41698-023-00413-9.
4
Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type.H3K27改变的小儿弥漫性中线胶质瘤:一种定义明确的肿瘤类型背后复杂的临床和生物学情况。
Front Oncol. 2023 Jan 16;12:1082062. doi: 10.3389/fonc.2022.1082062. eCollection 2022.
5
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study.定性和定量磁共振成像表型可预测异柠檬酸脱氢酶突变型星形细胞瘤中 CDKN2A/B 纯合缺失状态:一项多中心研究。
Korean J Radiol. 2023 Feb;24(2):133-144. doi: 10.3348/kjr.2022.0732.
6
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered.弥散性中线胶质瘤、H3 K27 改变型和无 H3 K27 改变型中线胶质瘤的 MRI 对比研究。
BMC Neurol. 2022 Dec 22;22(1):498. doi: 10.1186/s12883-022-03026-0.
7
Validation of MRI-Based Models to Predict MGMT Promoter Methylation in Gliomas: BraTS 2021 Radiogenomics Challenge.基于MRI的模型预测胶质瘤中MGMT启动子甲基化的验证:BraTS 2021放射基因组学挑战
Cancers (Basel). 2022 Oct 3;14(19):4827. doi: 10.3390/cancers14194827.
8
Radiomics-guided radiation therapy: opportunities and challenges.影像组学引导的放射治疗:机遇与挑战。
Phys Med Biol. 2022 Jun 13;67(12). doi: 10.1088/1361-6560/ac6fab.
9
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.替莫唑胺联合纳武利尤单抗或安慰剂治疗新诊断伴甲基化 MGMT 启动子的胶质母细胞瘤的 III 期临床试验。
Neuro Oncol. 2022 Nov 2;24(11):1935-1949. doi: 10.1093/neuonc/noac116.
10
Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma.基于放射组学的机器学习在多中心 PD-L1 抑制免疫治疗胶质母细胞瘤的 II 期研究中的预后预测。
AJNR Am J Neuroradiol. 2022 May;43(5):675-681. doi: 10.3174/ajnr.A7488. Epub 2022 Apr 28.

胶质瘤的影像基因组学再探讨:理解空间和时间异质性的分析方法。

Imaging Genomics of Glioma Revisited: Analytic Methods to Understand Spatial and Temporal Heterogeneity.

机构信息

From the Department of Radiation Medicine (C.N.K.), Oregon Health and Science University, Portland, Oregon.

Department of Radiology and Research Institute of Radiology (M.K., J.E.P.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

AJNR Am J Neuroradiol. 2024 May 9;45(5):537-548. doi: 10.3174/ajnr.A8148.

DOI:10.3174/ajnr.A8148
PMID:38548303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288537/
Abstract

An improved understanding of the cellular and molecular biologic processes responsible for brain tumor development, growth, and resistance to therapy is fundamental to improving clinical outcomes. Imaging genomics is the study of the relationships between microscopic, genetic, and molecular biologic features and macroscopic imaging features. Imaging genomics is beginning to shift clinical paradigms for diagnosing and treating brain tumors. This article provides an overview of imaging genomics in gliomas, in which imaging data including hallmarks such as -mutation, methylation, and -mutation status can provide critical insights into the pretreatment and posttreatment stages. This article will accomplish the following: 1) review the methods used in imaging genomics, including visual analysis, quantitative analysis, and radiomics analysis; 2) recommend suitable analytic methods for imaging genomics according to biologic characteristics; 3) discuss the clinical applicability of imaging genomics; and 4) introduce subregional tumor habitat analysis with the goal of guiding future radiogenetics research endeavors toward translation into critically needed clinical applications.

摘要

对导致脑肿瘤发生、发展和对治疗产生抵抗的细胞和分子生物学过程的深入理解,是改善临床结果的基础。影像基因组学是研究微观遗传、分子生物学特征与宏观影像学特征之间关系的学科。影像基因组学开始改变脑肿瘤的临床诊断和治疗模式。本文概述了影像基因组学在神经胶质瘤中的应用,其中影像学数据(包括突变、甲基化和基因融合状态等特征)可为治疗前和治疗后阶段提供重要信息。本文将完成以下目标:1)综述影像基因组学中使用的方法,包括视觉分析、定量分析和放射组学分析;2)根据生物学特征推荐合适的影像基因组学分析方法;3)讨论影像基因组学的临床应用;4)介绍亚区肿瘤生境分析,旨在指导未来的放射遗传学研究工作,使其转化为迫切需要的临床应用。